JAK inhibitors: beyond spleen and symptoms?
Francisco
F
Cervantes
Ruben
R
Mesa
Claire
C
Harrison
D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D053612:Janus Kinases / Q000037:antagonists & inhibitors*; D055728:Primary Myelofibrosis / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D016896:Treatment Outcome
D047428:Protein Kinase Inhibitors; D053612:Janus Kinases